JPRN-jRCTs071200105招募中2 期
Quality of life for patients with patients with Esophago-gastric cancer receiving neo adjuvant chemotherapy followed by Surgery by TJ-48 (Juzentaihoto) - QuEST study
Kobayashi Kazuma0 个研究点目标入组 90 人开始时间: 2021年3月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.The age at the time of obtaining consent is 20 years old or older.
- •2.Written consent has been obtained from the patient to be a research subject for this protocol treatment.
- •3.The institutional research director decided that this protocol can be used for treatment or the registration is appropriate.
- •4.Histologically confirmed to be an esophageal cancer; squamous cell carcinoma, adenosquamous carcinoma, basal cell carcinoma or adenocarcinoma, or a gastric cancer; one of the general types of histological classification.
- •5.The clinical stage is cstage II or III according to the TNM classification.
- •6.Preoperative chemotherapy has been judged clinically appropriate and has been decided.
- •7.No history of surgical treatment for esophageal cancer or gastric cancer. However, endoscopic treatment is eligible.
- •8.No history of chemotherapy, radiation therapy or endocrine therapy for esophageal cancer and gastric cancer.
- •9.Have one or more complaints of loss of appetite, malaise and weakness.
- •10.Radical surgery (R0) is judged to be possible by the esophagectomy or gastrectomy.
- •11.The performance status (PS) is either 0 or 1 by the ECOG scale.
- •12.Laboratory test done within 14 days prior to the registration meet the following criteria. For the laboratory test, blood transfusion or administrating the hematopoietic factor preparations cannot be done within 14 days before the test date.
- •Neutrophil counts >= 1,500/uL
- •Platelets>= 100,000 /uL
- •Hemoglobin >= 10.0 g/dL
- •Total bilirubin <= 1.5 mg/dL
- •AST<= 100 IU/L
- •ALT<= 100 IU/L
- •Serum creatinine <= 1.5 mg/dL
- •Creatinine clearance >= 40 mL/min
排除标准
- •Exclusion Criteria1.Received blood transfusion, blood products and hematopoietic factor preparations such as G-CSF within 14 days before the registration.
- •2.Has severe drug hypersensitivity
- •3.Has an active infection; have a fever of 38.0 degrees Celsius or higher and bacterial infection has been confirmed by a diagnostic imaging or bacterial examinations. Local infections that do not affect general conditions will be excluded.
- •4.Esophageal cancer cases requiring combined laryngectomy
- •5.Has uncontrolled hypertension or diabetes. (Diabetes controlled by insulin injection is eligible.)
- •6.The 12-lead ECG shows significant abnormalities or has clinically relevant heart disease within 28 days prior to registration.
- •7.Has intestinal pneumonia, pulmonary fibrosis, severe emphysema etc. by diagnostic imaging such as CT scan.
- •8.Has a history of autoimmune disease or chronic and/or recurrent autoimmune diseases. (Cases with type I diabetes, hypothyroidism that can be treated with hormone replacement therapy, and skin diseases that do not require systemic treatment are eligible.)
- •9.Needs an administration of systemic corticosteroids and immunosuppressants. (Excludes prophylactic administration or temporary use for tests or allergic reactions.)
- •10.Cases taking herbal medicine. (If the administration of the herbal medicine have finished 4 weeks before the registration, it is acceptable.)
- •11.Has psychosis or psychiatric symptoms that it is difficult to participate.
- •12.Has fresh bleeding from the gastrointestinal tract that requires repeated blood transfusions.
- •13.Has a history of myocardial infarction or unstable angina within 6 months of registration.
- •14.Has CTCAE Grade 2 or higher diarrhea or chronic watery stools.
- •15.Has active double cancer. (Cases with a history of other cancers that have not recurred for more than 5 years is eligible.)
- •16.Pregnant or lactating women or women who may be pregnant, and men who wish that his partner to be pregnant.
- •17.HBs antigen positive, HCV antibody positive or HIV antibody positive. (Test for HIV is not necessary.)
- •18.The cases that principal investigator or the physician in charge judged to be inappropriate for this study.
研究者
相似试验
尚未招募
不适用
Assessment of quality of life off patients who were operated for facial fracturesCTRI/2020/07/026650Manipal College of Dental Sciences Manipal
已完成
不适用
Evaluation of the quality of life of patients after anatomical lung resection in NSCLC taking psychosocial factors into consideratioC34F32F43.2Malignant neoplasm of bronchus and lungDepressive episodeAdjustment disordersDRKS00021762Charité Berlin168
尚未招募
不适用
A study on quality of life in Prosthakola veekkam (Benign prostatic hyperplasia) patients taking siddha treatmentCTRI/2023/02/049626ational Institute of Siddha
已完成
不适用
Enhancing quality of life in patients with chronic heart failure: A feasibility study of a mindfulness-based psychological interventioNL-OMON29818niversiteit van Tilburg30
招募中
不适用
Evaluation of quality of life of patients with food allergy and their guardians using a questionnairefood allergyJPRN-UMIN000044751ational Hospital Organization Sagamihara National Hospital200